What Happened

EliseAI is in talks to raise $300M at a $3.7B valuation, according to a Business Insider report published Tuesday by Katie Roof. Andreessen Horowitz and Bessemer Venture Partners are reportedly in discussions to lead the round. All three parties — EliseAI, a16z, and Bessemer — declined to comment, which means every figure describes a deal in progress, not a closed transaction.

If the reported terms hold, the valuation would represent a $1.5B jump from EliseAI's last round: a $250M Series E in August 2025 at a $2.2B valuation, led by a16z with Bessemer and Sapphire Ventures participating. That round itself more than doubled the $1B mark set during the company's $75M Series D in August 2024, led by Sapphire Ventures.

The trajectory is steep: from unicorn status in August 2024 to a potential $3.7B valuation two years later, with each round more than doubling the previous mark.

Why It Matters

This round is a signal about where late-stage AI capital is actually flowing — and it's not toward foundation models or consumer applications. EliseAI sells AI assistants that handle tenant communications, book apartment tours, log maintenance requests, and, since 2023, manage healthcare front-desk operations including patient scheduling and invoicing. The product is deliberately unglamorous.

What justifies the markup is $100M+ in annual recurring revenue, reportedly crossed in early 2025. In a funding climate where Business Insider notes many AI startups are struggling to raise at all, a company adding $1.5B in paper value in twelve months is either an outlier or a signal about where investors think durable revenue sits. The answer appears to be: narrow, workflow-specific automation in incumbent-heavy markets where switching costs are high and competition is fragmented.

The healthcare expansion is the strategic move investors seem to be paying for. A front desk that books apartment tours and one that books patient appointments are, in software terms, close cousins. EliseAI effectively doubled its addressable market without rebuilding its core product — and the property management software market alone is projected to grow from $6.53B in 2026 to $9.93B by 2031, per Mordor Intelligence.

Who Is Affected

AI startup founders building vertical automation tools should study this valuation as a case study in what investors reward: real ARR, sticky contracts, and expansion into adjacent verticals with minimal product changes. The 37x revenue multiple at $3.7B on $100M ARR is aggressive but defensible when the revenue recurs and the market is underpenetrated.

Property managers and healthcare operators should expect intensified sales activity from AI automation vendors. EliseAI's competitors include Lette AI, Dwelly (UK), and incumbents like AppFolio, Yardi, Entrata, and RealPage. Flow, Adam Neumann's venture valued at $2.5B in 2025, is taking a different approach by owning buildings rather than selling software.

Investors should note that a16z is leading this round while simultaneously facing a US Justice Department investigation into whether its partners hold competing board seats across rival companies. The inquiry doesn't touch EliseAI directly, but it sits over every round a16z now leads.

Strategic Implications

For AI startup founders: The EliseAI playbook is clear — pick a slow-moving vertical with entrenched incumbents (Yardi, RealPage in property; Epic, Cerner in healthcare), build a narrow automation layer that removes repetitive human tasks, prove ARR, then expand into an adjacent vertical where the workflow is structurally similar. The valuation follows the revenue, not the vision.

For developers/operators building with AI APIs: The reusable insight is workflow portability. Scheduling, triage, and intake orchestration patterns transfer across industries with surprisingly little adaptation. If you're building agentic systems, design the core abstraction layer to be vertical-agnostic from day one — EliseAI's healthcare pivot worked because the underlying task graph was identical.

For non-technical business owners evaluating AI tools: The vendors worth testing are the ones that integrate deeply with your existing systems (property management platforms, EHRs, billing systems) rather than offering standalone chatbots. The ROI case is headcount reduction on routine tickets — if a vendor can't show you exactly which FTE-hours their tool eliminates, the pitch isn't ready.

What to Watch Next

Monitor for deal confirmation — a close at or near the reported $300M/$3.7B terms would validate the vertical-AI valuation thesis. Also watch whether a16z's DOJ investigation affects its ability to take board seats in new portfolio companies, which could reshape lead-investor dynamics across AI funding rounds this quarter.

Frequently Asked Questions

Q: What does EliseAI do?

A: EliseAI builds AI assistants that automate routine communications and scheduling for property managers (tenant inquiries, apartment tour booking, maintenance requests) and healthcare providers (patient appointments, invoicing, billing). Founded in 2017, the company serves thousands of housing units and expanded into healthcare in 2023.

Q: How much revenue does EliseAI generate?

A: EliseAI reportedly passed $100 million in annual recurring revenue (ARR) in early 2025. The company has grown headcount from approximately 150 to over 300 since its Series D round in August 2024.

Q: Is the $300M funding round confirmed?

A: No. The round is in talks, not closed. Business Insider reported the figures citing sources familiar with the deal, but EliseAI, a16z, and Bessemer all declined to comment. The reported numbers could still change before a final close.